{"transactions":[{"id":2195765,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (right to buy)","published_at":"2022-08-03T20:30:45.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":720260,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 25% on August 1, 2023 with the remainder to vest in 36 equal monthly installments thereafter."}],"balance_after":720260,"derivative":{"exercise_price":0.1757,"expiration_date":"2022-08-02","underlying":"Common Stock","underlying_shares":720260},"source":{"system":"sec-edgar","filing":"0001493152-22-021172","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000149315222021172/ownership.xml","form_type":"4"}},{"id":2195764,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-03T20:30:45.000Z","date":"2022-08-01","kind":"grant","acquired":true,"shares":240087,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 240,087 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in 4 equal annual installments beginning on August 1, 2023."}],"balance_after":277273,"source":{"system":"sec-edgar","filing":"0001493152-22-021172","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000149315222021172/ownership.xml","form_type":"4"}},{"id":2478919,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-09T21:09:59.000Z","date":"2021-12-08","kind":"purchase","acquired":true,"shares":28700,"price":0.677,"value":19429.9,"ownership":{"direct":true},"balance_after":37186,"source":{"system":"sec-edgar","filing":"0000899243-21-047520","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089924321047520/doc4.xml","form_type":"4"}},{"id":2735835,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-04-29T20:06:02.000Z","date":"2021-04-29","kind":"exercise","acquired":false,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock."}],"balance_after":0,"derivative":{"exercise_date":"2016-04-29","underlying":"Common Stock","underlying_shares":938},"source":{"system":"sec-edgar","filing":"0000905718-21-000630","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000630/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2735834,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-29T20:06:02.000Z","date":"2021-04-29","kind":"exercise","acquired":true,"shares":938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Each share of Series B Preferred Stock was mandatorily converted on April 29, 2021 pursuant to the terms of the Series B Preferred Stock set forth in the Certificate of Designations of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series B Preferred Stock was convertible into 0.25 shares of common stock equating to a conversion price of $32.00."}],"balance_after":8486,"source":{"system":"sec-edgar","filing":"0000905718-21-000630","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000630/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2735833,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-04-29T20:06:02.000Z","date":"2021-04-29","kind":"other","acquired":true,"shares":8,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends to April 29, 2021 on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7548,"source":{"system":"sec-edgar","filing":"0000905718-21-000630","document":"kintara_fm4apr292021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000630/kintara_fm4apr292021.xml","form_type":"4"}},{"id":2766364,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-03-31T20:08:33.000Z","date":"2021-03-31","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7540,"source":{"system":"sec-edgar","filing":"0000905718-21-000501","document":"kintara_fm4mar312021.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571821000501/kintara_fm4mar312021.xml","form_type":"4"}},{"id":2925630,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-01-04T13:00:23.000Z","date":"2020-12-31","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7518,"source":{"system":"sec-edgar","filing":"0000899243-21-000042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000089924321000042/doc4.xml","form_type":"4"}},{"id":3019857,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-09-30T20:06:16.000Z","date":"2020-09-30","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7496,"source":{"system":"sec-edgar","filing":"0000905718-20-000998","document":"kintara_fm4sep302020.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000998/kintara_fm4sep302020.xml","form_type":"4"}},{"id":3028430,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (Right to Buy)","published_at":"2020-09-18T01:12:10.000Z","date":"2020-09-15","kind":"grant","acquired":true,"shares":606557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made to reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to continued employment, 1/6th of the options vest on March 15, 2021, with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 15, 2021."}],"balance_after":606557,"derivative":{"exercise_price":1.7,"expiration_date":"2030-09-15","underlying":"Common Stock","underlying_shares":606557},"source":{"system":"sec-edgar","filing":"0000905718-20-000975","document":"kintara_fm4sep152020.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000975/kintara_fm4sep152020.xml","form_type":"4"}},{"id":3096579,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Option (Right to Buy)","published_at":"2020-06-30T20:17:36.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":57170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On September 5, 2019, the reporting person received options to purchase 57,170 shares which were subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the 2020 Annual Meeting of Stockholders. Stockholder approval of the increase was obtained on June 26, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/6th of the options vested on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months which commenced on April 5, 2020."}],"balance_after":108366,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":57170},"source":{"system":"sec-edgar","filing":"0001213900-20-016319","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020016319/ownership.xml","form_type":"4"}},{"id":3096578,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-06-30T20:17:36.000Z","date":"2020-06-30","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7474,"source":{"system":"sec-edgar","filing":"0001213900-20-016319","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020016319/ownership.xml","form_type":"4"}},{"id":3190859,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-03-31T20:28:43.000Z","date":"2020-03-31","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7452,"source":{"system":"sec-edgar","filing":"0001213900-20-008229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390020008229/ownership.xml","form_type":"4"}},{"id":3327141,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-02T21:17:48.000Z","date":"2019-12-31","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7430,"source":{"system":"sec-edgar","filing":"0000905718-20-000018","document":"delmarph_fm4dec32019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571820000018/delmarph_fm4dec32019.xml","form_type":"4"}},{"id":3403116,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-10-01T20:14:54.000Z","date":"2019-09-30","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":7408,"source":{"system":"sec-edgar","filing":"0000905718-19-000811","document":"delmarph_fm4sept302019.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000811/delmarph_fm4sept302019.xml","form_type":"4"}},{"id":3419569,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:34:17.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":51196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/6th of the options vest on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020."}],"balance_after":51196,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":51196},"source":{"system":"sec-edgar","filing":"0000905718-19-000759","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000759/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3419568,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (Right to Buy)","published_at":"2019-09-09T20:34:17.000Z","date":"2019-09-05","kind":"grant","acquired":true,"shares":57170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, 1/6th of the options vest on March 5, 2020 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on April 5, 2020."}],"balance_after":57170,"derivative":{"exercise_price":0.61,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":57170},"source":{"system":"sec-edgar","filing":"0000905718-19-000759","document":"delmarph_fm4sept52019.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571819000759/delmarph_fm4sept52019.xml","form_type":"4"}},{"id":3474708,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-01T20:21:42.000Z","date":"2019-06-28","kind":"other","acquired":true,"shares":22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On May 8, 2019, the issuer effected a 1-for-10 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":7386,"source":{"system":"sec-edgar","filing":"0001213900-19-011882","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019011882/ownership.xml","form_type":"4"}},{"id":3571949,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-04-01T20:38:57.000Z","date":"2019-03-29","kind":"other","acquired":true,"shares":211,"price":0.49,"value":103.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":73632,"source":{"system":"sec-edgar","filing":"0001213900-19-005506","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019005506/ownership.xml","form_type":"4"}},{"id":3713408,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-01-02T23:20:24.000Z","date":"2018-12-31","kind":"other","acquired":true,"shares":211,"price":0.3419,"value":72.1409,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":73421,"source":{"system":"sec-edgar","filing":"0001213900-19-000055","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390019000055/ownership.xml","form_type":"4"}},{"id":3766902,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-13T21:37:55.000Z","date":"2018-11-08","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/6th of the options vest on May 8, 2019 with the remaining shares vesting in equal monthly installments over a period of 30 months commencing on June 8, 2019."}],"balance_after":100000,"derivative":{"exercise_price":0.6099,"expiration_date":"2028-11-08","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001213900-18-015512","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018015512/ownership.xml","form_type":"4"}},{"id":3804335,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-10-01T20:08:31.000Z","date":"2018-09-28","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":73210,"source":{"system":"sec-edgar","filing":"0001213900-18-013297","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018013297/ownership.xml","form_type":"4"}},{"id":3875079,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-03T20:41:59.000Z","date":"2018-06-29","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":72999,"source":{"system":"sec-edgar","filing":"0001213900-18-008714","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018008714/ownership.xml","form_type":"4"}},{"id":3973139,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-04-03T20:08:52.000Z","date":"2018-03-30","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":72788,"source":{"system":"sec-edgar","filing":"0001213900-18-003991","document":"f4033018praill_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390018003991/f4033018praill_delmar.xml","form_type":"4"}},{"id":4112180,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Exchangeable Shares","published_at":"2018-01-03T21:55:50.000Z","date":"2017-12-31","kind":"exercise","acquired":false,"shares":25000,"price":2,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000905718-18-000012","document":"praill_form4dec312017.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571818000012/praill_form4dec312017.xml","form_type":"4"}},{"id":4112179,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:55:50.000Z","date":"2017-12-31","kind":"exercise","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Exchangeable Shares are shares of a wholly-owned subsidiary of the Issuer that are exchangeable at any time for shares of common stock in the Issuer on the basis of one Exchangeable Share for one share of common stock."}],"balance_after":72577,"source":{"system":"sec-edgar","filing":"0000905718-18-000012","document":"praill_form4dec312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571818000012/praill_form4dec312017.xml","form_type":"4"}},{"id":4112178,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Anthony Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-01-03T21:55:50.000Z","date":"2017-12-31","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":47577,"source":{"system":"sec-edgar","filing":"0000905718-18-000012","document":"praill_form4dec312017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000090571818000012/praill_form4dec312017.xml","form_type":"4"}},{"id":4191029,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial  Officer"}}],"security":"Common Stock","published_at":"2017-10-05T22:05:04.000Z","date":"2017-10-05","kind":"purchase","acquired":true,"shares":17500,"price":0.852,"value":14910.0,"ownership":{"direct":true},"balance_after":47366,"source":{"system":"sec-edgar","filing":"0001213900-17-010332","document":"f4100517praill_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017010332/f4100517praill_delmar.xml","form_type":"4"}},{"id":4197770,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial  Officer"}}],"security":"Common Stock","published_at":"2017-10-02T23:50:33.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":29866,"source":{"system":"sec-edgar","filing":"0001213900-17-010206","document":"f4092917praill_delmarpharm.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017010206/f4092917praill_delmarpharm.xml","form_type":"4"}},{"id":4264462,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-07-05T18:30:24.000Z","date":"2017-06-30","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":29655,"source":{"system":"sec-edgar","filing":"0001213900-17-007149","document":"f4063017praill_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017007149/f4063017praill_delmarpharma.xml","form_type":"4"}},{"id":4271066,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial  Officer"}}],"security":"Common Stock","published_at":"2017-06-28T15:34:33.000Z","date":"2017-06-26","kind":"purchase","acquired":true,"shares":4167,"price":3.6,"value":15001.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person purchased the shares in a private transaction for an aggregate purchase price of CDN $20,000. Reported price is based on exchange rate of 0.75."}],"balance_after":29444,"source":{"system":"sec-edgar","filing":"0001213900-17-006886","document":"f4062617praill_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017006886/f4062617praill_delmarpharma.xml","form_type":"4"}},{"id":4291087,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-06-06T21:23:24.000Z","date":"2017-06-06","kind":"purchase","acquired":true,"shares":9500,"price":2.1,"value":19950.0,"ownership":{"direct":true},"balance_after":25277,"source":{"system":"sec-edgar","filing":"0001213900-17-006200","document":"f4060617praill_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017006200/f4060617praill_delmarpharma.xml","form_type":"4"}},{"id":4365211,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial  Officer"}}],"security":"Common Stock","published_at":"2017-04-03T22:16:22.000Z","date":"2017-03-31","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":15777,"source":{"system":"sec-edgar","filing":"0001213900-17-003272","document":"f4033117praill_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017003272/f4033117praill_delmar.xml","form_type":"4"}},{"id":4431586,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Options (Right to Buy)","published_at":"2017-02-22T21:25:20.000Z","date":"2017-02-17","kind":"grant","acquired":true,"shares":37400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in equal monthly installments over three years."}],"balance_after":37400,"derivative":{"exercise_price":4.95,"exercise_date":"2020-02-17","expiration_date":"2027-02-17","underlying":"Common Stock","underlying_shares":37400},"source":{"system":"sec-edgar","filing":"0001213900-17-001713","document":"f4021717praill_delmarpharma.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017001713/f4021717praill_delmarpharma.xml","form_type":"4"}},{"id":4507968,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-01-03T18:54:10.000Z","date":"2016-12-31","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":15566,"source":{"system":"sec-edgar","filing":"0001213900-17-000020","document":"f4123116praill_delmar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390017000020/f4123116praill_delmar.xml","form_type":"4"}},{"id":4586952,"issuer":{"id":6601,"kind":"organization","name":"TuHURA Biosciences, Inc./NV"},"owners":[{"id":124937,"kind":"person","name":"Praill Anthony Scott","position":1,"cik":"0001332948","reported_name":"Praill Scott","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial  Officer"}}],"security":"Common Stock","published_at":"2016-10-04T22:20:19.000Z","date":"2016-10-03","kind":"other","acquired":true,"shares":211,"price":3.2,"value":675.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock."}],"balance_after":15355,"source":{"system":"sec-edgar","filing":"0001213900-16-017277","document":"f4100316praill_delmarpharma.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1498382/000121390016017277/f4100316praill_delmarpharma.xml","form_type":"4"}}]}